Introduction
Introduction
Orofacial bone mesenchymal stem cells (OFMSCs) from maxilla and mandible are postnatal mesenchymal stem cells with inherently higher survival and osteogenic properties than bone mesenchymal stem cells (BMSCs) from non-oral bones (1, 2) . We have previously shown that in same individuals, BMSCs in the jaw (i.e. OFMSCs) are skeletally site-specific based on proliferation, survival, differentiation and in vivo regenerative properties (1) (2) (3) . A combination of the biology of the local microenvironment and circulating levels of soluble calcium and inorganic phosphates have been correlated with bone regeneration (4, 5) ; therefore calcium-silicate cements also known as Mineral Trioxide Aggregates (MTA) cements are used clinically in oral surgery and root canal therapy. Calcium-silicate cements have attractive chemical, physical and biological properties that include ability to set in the presence of moisture, the release of calcium ions, and ability to form apatite in the presence of phosphate-containing simulated-body fluids (6) (7) (8) (9) (10) (11) .
The bioactive properties of calcium-silicate cements combined with bio-interactivity (12) with local microenvironment may be conducive to cell survival and bone regeneration (13) , but there is paucity of information on effects of calcium-silicate cements on jaw specific mesenchymal stem cells (14) . Alpha-tricalcium phosphate (α-TCP) is a reactive compound that can serve as a source of phosphate (15) and calcium ions (16) for apatite formation (17) and tissue regeneration. Although calcium-silicate cements are more resorbable than hydroxyapatite-tricalcium phosphate commonly used to promote bone regeneration, they can potentially stimulate appropriate biomimetic microenvironments for OFMSC differentiation because they have been shown to promote attachment and proliferation of osteoblast-like cells and dental pulp stem cells (DPSCs) (5, 18) . DPSCs share similar embryological origin with OFMSCs (1, 19) but OFMSCs display higher osteogenic differentiation (2) . A combination of superior osteogenesis of OFMSCs with biomimetic properties of calcium-silicate cements is attractive for bone regeneration, but biocompatibility of calcium-silicate material extracts with survival and regenerative properties of OFMSCs are still unclear.
The aim of this study was to determine the biocompatibility of OFMSCs with biomimetic properties of two calcium-silicate preparations: 1) calcium-silicate mineral powder (wTC) containing di-and tricalcium-silicate, calcium sulphate and calcium chloride; and 2) wTC doped with alpha-tricalcium phosphate (wTC-αTCP). We hypothesized that calcium ions and other minerals (silicon and phosphorous) in material extracts released by calciumsilicate cements will provide supportive biomimetic microenvironment for survival and differentiation of human OFMSCs.
Materials and Methods

Preparation of calcium silicate cements
Experimental calcium-silicate mineral powder (wTC) containing di-and tricalcium-silicate, calcium sulphate, calcium chloride; and another wTC doped with alpha-tricalcium phosphate (wTC-αTCP) were designed and produced. The grinded mineral powders were mixed using 1 g of cement per 0.300 ml of calcium and magnesium free Dulbecco s Phosphate Buffered Saline (DPBS) pH 7.4 (Lonza Walkersville Inc, Walkersville, MD, USA, Cat #17-512) on a glass plate with stainless-steel spatula. A homogeneous paste was achieved within 30 seconds and packed into a circular polyvinyl chloride (PVC) mold (8 mm internal diameter and 1.6 mm thickness) to obtain a smooth surface.
Setting times of cements
Calcium-silicate cement (wTC and wTC-αTCP) discs covered on upper and lower surfaces with wet gauze to prevent dehydration were placed in a hermetically sealed curing chamber (37°C and 98% relative humidity) before evaluating setting times. Gilmore needles were used to assess setting times according to ASTM C266-03 (American Society for Testing and Materials International) and ISO 9917-1 (International Organization for Standardization) (20, 21) . Briefly described, Gilmore initial setting time was the elapsed time (in minutes) between the mixing of the cement with liquid and the first penetration measurement that does not mark the specimen surface with a complete circular impression. As either the initial or final setting times approached (i.e. no indentation), the specimens were tested every minute to determine the exact Gilmore setting time. Following initial setting time, the specimens were assessed every 5 minutes until final stetting time was determined. Weight/ diameter of Gilmore needle used were 113.4 g/2.12 mm and 453.6-g/1.06 mm to test initial and final setting times respectively (20) . Setting time testing was performed on three replicates for each material and each sample was used for only one indentation test.
Calcium release and alkalinizing activity of cements
Calcium-silicate cement (wTC and wTC-αTCP) discs (n=10 for each material) were immediately immersed in 10 ml of deionized water (pH 6.8) in polypropylene sealed containers at 37°C. Soaking water was collected at 3 and 24 hours and after 7, 14 and 28 days to assess pH and calcium content. Calcium released in soaking water was measured using a calcium probe (Calcium ion electrode, Eutech instruments Pte Ldt, Singapore) after addition of 0.200 ml (2%) of ionic strength adjuster (ISA, 4 mol/L KCl, WTW, Weilheim, Germany). The pH of soaking water was measured using a selective temperature compensated electrode (Sen Tix Sur WTW, Weilheim, Germany) and a previously calibrated multi-parameter laboratory meter (inoLab 750, WTW Weilheim, Germany). The probes were inserted into the soaking media at room temperature (24°C) with continuous stirring. Each measurement was repeated three times.
Calcium-silicate disc and extract preparations for cell culture
Calcium-silicate cement (wTC and wTC-αTCP) discs for OFMSC culture were prepared as above using a circular PVC mold (12 mm internal diameter and 1.6 mm thickness). To obtain partial setting, cements were kept for 1 hour at 37°C and 95% relative humidity to allow for hydration and setting reactions. Cements discs were de-molded and sterilized for 2 hours in antibiotic medium consisting of α-modified minimum essential medium (α-MEM), 100 U/ml penicillin, 100 mg/ml streptomycin sulfate and 25 μg/ml amphotericin B. Discs were washed free of antibiotic medium with sterile PBS before using for cell attachment assay. Cement discs prepared in the similar manner as above were allowed to set for 1 hour at room temperature instead of 37°C, transferred to a 24-well culture plate and sterilized with antibiotic medium as above. Discs were incubated in 1.5 ml fresh α-MEM containing 100 U/ml penicillin, 100 mg/ml streptomycin sulfate and 2 mM glutamine at 37°C in humidified atmosphere for 24 hours to allow for release of calcium and silicate ions into the medium. The supernatant collected was referred to as material extract. wTC and wTC-αTCP material extracts were passed through separate 0.22 μm filters, pH recorded with colorimetric strips, and kept at 4°C until used for cell culture.
Culture of orofacial bone mesenchymal stem cells
Human OFMSCs were expanded from primary cultures of human maxilla and mandible primary bone mesenchymal stem cells previously isolated under an existing protocol approved by the University of Pennsylvania Institutional Review Board. The cells were cultured in growth medium consisting of α-MEM supplemented with 10% fetal bovine serum (FBS) (Equitech Bio Inc., Kerville TX), 100 U/ml penicillin, 100 mg/ml streptomycin sulfate and 2 mM glutamine (BioSource International Camarillo CA), incubated at 37ºC in a humidified atmosphere of 5% CO 2 and air as previously described (1) . Passage 3 OFMSCs were used for all experiments.
Attachment of OFMSCs to calcium-silicate discs
Sterile 12 mm diameter wTC and wTC-αTCP discs prepared as above were transferred into separate wells of a 24-well culture plate containing α-MEM growth medium. 2.0 × 10 4 OFMSCs were seeded on triplicate wTC and wTC-αTCP discs and in blank wells so that tissue culture plastic served as control. After 24 hours, the discs were transferred to another 24-well plate. Attached cells were released with trypsin/EDTA and cell scraper before counting with a hemocytometer.
OFMSC survival in calcium-silicate extracts
OFMSCs were seeded in 96-well plate at 3.2 × 10 4 cells per well. After 24 hours, α-MEM growth medium was changed so that three sets of 11 wells received extract of wTC or wTC-αTCP or fresh α-MEM growth medium. After another 72 hours in culture, surviving cells were assessed using colorimetric WST-1 cell proliferation assay (Roche Applied Science, Indianapolis, IN, USA) according to manufacturer s instructions.
Lineage differentiation of OFMSCs in calcium-silicate extracts
Osteogenesis-OFMSCs seeded at 9.5 × 10 4 cells per well in duplicate wells of a 6-well plate were kept in culture for 24 hours before exposure to either wTC or wTC-αTCP material extract prepared as above. Control cells received fresh α-MEM growth medium. After 48 hours, the cells were replenished with osteogenic medium consisting of α-MEM, 10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin sulfate, 2 mM glutamine, 10 −8 M dexamethasone and 100 μM L-ascorbic acid phosphate magnesium-hydrate. After another 48 hours, total protein was collected using Mammalian Protein Extraction Reagent (M-PER, Pierce Biotechnology, Rockford, IL). In a similar set up of parallel experiment, total RNA was isolated with Trizol reagent (Invitrogen, Carlsbad, CA).
Western blotting-Protein amount was determined with BCA protein assay (Pierce Biotechnology, Rockford, IL). 50 μg protein was separated in 4-12% Bis-Tris gel (Invitrogen, Carlsbad, CA) under reducing conditions and western blotting was performed as previously described (3 Real time-PCR-cDNA was prepared from 2 mg of total RNA using oligo(dT) and SuperScript First-Strand Synthesis System for reverse transcriptase PCR (Invitrogen, Carlsbad, CA). Real-time PCR reaction was performed in ABI 7300 Real-Time PCR System using Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) and primer sets designed with Primer Express software (Applied Biosystems, Foster City, CA) and GenBank sequences for: human VCAM-1 -forward, 5′-GAAGGAATTAACCAGGCTGGAA-3′, reverse, 5′-AGTTTTATGTCTTTTGGAGTAACTTG-3′; human ALP -forward, 5′-CCGTGGCAACTCTATCTTTGG-3′, reverse, 5′-GATGGCAGTGAAGGGCTTCTT-3′; human BSP -forward, 5′-AACGAAGAAAGCGAAGCAGAA-3′, reverse, 5′-TCTGCCTCTGTGCTGTTGGT-3′ and human TATA binding protein (TBP) -forward, 5′-GGAGCTGTGATGTGAAGTTTCCTA-3′, reverse, 5′-CCAGGAAATAACTCTGGCTCATAAC-3′ used as endogenous control. A negative PCR control without template was included in each assay. Gene expression levels normalized to TBP and presented as relative fold change using the ΔΔCt method (Applied Biosystems, Foster City, CA) was used to quantify changes in mRNA levels in response to material extracts. 4 OFMSCs plated in duplicate 60 mm dishes were treated with material extracts as above. They were further cultured for 4 weeks in adipogenic medium consisting of α-MEM supplemented with 10 −8 M dexamethasone, insulin (1 μg/ml), 1-methyl-3-isobutylxanthine (IBMX, 5 × 10 −8 M) and indomethacin (10 −4 M); medium was changed twice weekly. The cells were fixed with 4% paraformaldehyde, stained with 0.3% Oil Red O and counterstained with 1% Fast green dye. Lipid droplets were assessed microscopically.
Adipogenesis-2 × 10
In vivo bone regeneration by OFMSCs exposed to calcium-silicate extracts
Using both extract-exposed and control OFMSCs, 2 × 10 6 cells attached to 40 mg of spheroidal hydroxyapatite tricalcium phosphate (particle size 0.5-1.0 mm; Zimmer, Warsaw, IN, USA) were transplanted aseptically into separate subcutaneous pockets of 8-week-old immunocompromised female nude mice (NIH-III-nu; Charles River Laboratories, Wilmington, MA, USA) as previously described (1, 3) and in accordance with animal protocol approved by University of Pennsylvania Institutional Animal Care and Use Committee. Transplants were harvested at 6 weeks, fixed with 4% paraformaldehyde, decalcified in 10% ethylenediaminetetraacetic acid (EDTA) (pH 8.0) and embedded in paraffin. Hematoxylin eosin-stained 5 μm sections were evaluated and quantified microscopically as previously described (1, 3) .
Statistical analysis
Results were expressed as mean ± standard deviation (SD). Differences between groups were analysed with one-way analysis of variance (ANOVA) followed by post hoc comparisons with Tukey-Kramer test using SigmaStat 3.1, Systat Software, Inc., Chicago, IL). Statistical significance was set at P < 0.05.
Results
Setting reaction initiated earlier and hardness was completed faster in wTC-αTCP discs relative to wTC (Table 1) . Similarly, release of calcium ions in unset freshly prepared cement was also faster in wTC-αTCP within the first 3 hours, but wTC displayed a more gradual calcium release within the first 24 hours in spite of relatively similar pH of soaking solution (Table 2 ). Discs formed from partially and fully set wTC and wTC-αTCP cements maintained their rigidity and shape irrespective of setting parameters ( Figure 1A) . Attachment of OFMSCs to cement discs was much lower than tissue culture plastic (p =0.001) but wTC discs apparently supported slightly more cell attachment than wTC-αTCP ( Figure 1B) . Exposure of sub-confluent monolayer of OFMSCs to cement extracts reduced cell-to-cell contact and plastic adherence (Figures 1C-E ). There were evidences of cement sediments and free floating cells in the wTC and wTC-αTCP culture environments while control cells in α-MEM continued proliferation to 100% cell confluence ( Figures 1C-E) . Despite the sub-optimal culture conditions in material extracts, OFMSCs exposed to cement extracts displayed 80-98% survival relative to control cells in α-MEM but there was no statistically significant difference between wTC and wTC-αTCP extracts (p = 0.07) ( Figure  1F ). OFMSC levels of VCAM-1, a marker of cell attachment was unaffected by cement extracts based on western blot analysis (Figures 2A and B) , but mRNA expression was upregulated as shown by real time PCR (Figure 2C) . Similarly, protein levels of ALP and BSP remained at baseline level in OFMSCs exposed to cement extracts ( Figure 2B ) but mRNA levels of ALP and not BSP were distinctly upregulated by extracts of both wTC and wTC-αTCP ( Figure 2C ). There was no significant difference between wTC and wTC-αTCP. Interestingly, aggregates of fat droplets were fewer numerically but structurally larger in OFMCs pre-treated with material extracts relative to control cells (Figures 3A-C) . Similarly OFMSCs pre-treated with material extracts before transplantation into immunocompromised mice regenerated appreciable in vivo bone structurally (Figures 3D-F) and quantitatively ( Figure 3G ) similar to those of control cells.
Discussion
Large periapical bone defects pose a surgical challenge in endodontic practice. They often require the use of bioactive materials like calcium silicate to promote apical bone healing (22) (23) (24) . Calcium-silicate cements release calcium ions and the presence of Si-OH groups triggers the formation of a layer of apatite on the cement surface (6) . Both wTC and wTC-αTCP calcium-silicate cements tested in this study set rapidly and released appreciably high calcium ions within the first 24 hours of fluid exposure. The ion-releasing effect that gradually tapered down within 7 days can therefore counteract potential tissue accumulation and cytotoxicity. Calcium and silicon ions released from bioactive glasses have been shown to stimulate osteoblast proliferation and gene expression (25) (26) (27) . It is possible that calcium ion-releasing ability of cements tested in this study also favor OFMSC differentiation and jaw bone healing (28) . We found that OFMSCs attachment to cements was low relative to tissue culture plastic, but they maintained proliferation and survival in the calcium-rich extract generated by the cements. While both types of calcium-silicate cement set rapidly and maintained their rigidity to allow for cell attachment, the reduced OFMSC attachment observed is similar to previously described attachment to oxidized titanium commonly used to promote osseointegration of dental implants (19) . The relatively non-suppressible protein levels of VCAM-1, ALP and BSP and upregulation of their respective transcripts support ability of OFMSCs to differentiate in a calcium rich extract. Ability to induce adipogenesis and in vivo bone formation despite pre-treatment with cement extracts also support previous reports that osteoprogenitor cells respond to critical concentrations of calcium and silicate released by fresh cement surfaces (14, 28) and sol-gel bioactive glasses (29) . In spite of reduced OFMSC attachment and survival, the residual OFMSCs demonstrated enhanced adipogenesis and comparatively similar in vivo bone formation as control cells. Therefore, gradual release of calcium and silicate ions from calcium-silicate cements may represent another stimulatory signal for OFMSC differentiation. Apart from larger aggregates of lipid droplets, there were no significant differences between wTC and wTC-αTCP on OFMSCs differentiation. Previous reports have demonstrated that different α-TCP doped calciumsilicate cements have enhanced bioactivity i.e. faster/higher apatite-forming ability (30, 31) but they also slightly reduced the proliferation of human BMSCs seeded on their surface (13) .
Calcium-silicate cements have been proposed as root-end filling materials and root-canal sealers in endodontic therapy (23) . Specifically, wTC and wTC-αTCP formulations can be used in contact with bone to seal defects and apices of resected teeth after apicoectomy; hence they can promote periapical bone regeneration and healing. Our study indicates the compatibility of wTC and wTC-αTCP calcium-silicate cements with OFMSCs, so if cements leach into surrounding bone, survival of resident osteoprogenitor cells will be relatively unaffected. Although calcium-silicate is more resorbable and less osteoconductive than hydroxyapatite-tricalcium phosphate commonly used to stimulate MSCs to form bone (1, 19) , the present study shows that calcium-silicate cements have the potential to stimulate appropriate biomimetic microenvironments for OFMSC differentiation. Clinically, this property can ultimately promote rapid bone healing of large periapical bone defects following endodontic surgery. Additionally, we have previously reported that OFMSCs support hard tissue regeneration whether induced or non-induced (1); therefore, superior osteoregenerative and survival properties of OFMSCs in the milieu of ion-releasing calciumsilicates make OFMSCs attractive graft materials in endodontic surgery. Further studies are still warranted on the clinical applications of OFMSC-calcium silicate composite as donor grafts in endodontic surgery. Effect of calcium silicate cements on attachment and survival of OFMSCs. Representative images of calcium silicate cements within the PVC mold (A, top panel) and after recovery from the mold (A, lower panel) indicate rigidity of the calcium silicate discs was maintained irrespective of setting parameters. OFMSC attachment to silicate discs was significantly lower (p = 0.001) than cells attached to tissue culture plastic (B). Plastic adherence in α-MEM culture medium (C) was reduced when OFMSCs were introduced to cement extracts (D, E) as demonstrated by floating cells and partial loss of cell-to-cell contact. Metabolically active cells in calcium silicate extracts and α-MEM were similar based on WST-1 survival assay (F) and there were no significant differences between surviving cells in wTC and wTC-αTCP extracts (p = 0.074). [*** = p ≤ 0.001]. Effect of calcium silicate cements on adipogenesis and in vivo bone regeneration. Lipid aggregates (black arrow heads) were randomly distributed around majority of α-MEMcultured (control) OFMSCs (A), while wTC and wTC-αTCP extract-treated cells displayed fewer but structurally larger lipid aggregates (B, C) than control cells. Similarly OFMSCs pre-treated with material extracts regenerated appreciable in vivo bone (black solid arrows) structurally similar to those of control cells (D, E, F); and there were no differences in amount of bone regenerated by extract-treated and α-MEM-treated OFMSCs (G) [* = hydroxyapatite carrier; clear arrow = fibrous tissues].
